04/18/2018 | Press release | Distributed by Public on 04/16/2018 18:03
With 20+ hours of expert-led education delivering a deep dive on product development and R&D, engineers and managers, biomedical engineers, design engineers, project engineers, directors, and more know the BIOMEDevice Boston Conference is a must-attend for learning the latest strategies in turning concepts into competitive products
Dr. Sauer-Budge's talk is entitled, 'New Technologies for the Rapid Identification of Drug-Resistant Bacteria.'
The extensive use of antibiotics to treat infections, without first specifically identifying the cause, has resulted in a strong natural selection for antibiotic resistant organisms. Conservative estimates from the CDC indicate that more than two million people are sickened by antibiotic-resistant infections in the US each year, leading to more than 23,000 deaths. Because it takes days by traditional methods to identify the etiological organism and its drug-susceptibility profile, up to 50% of all antibiotics prescribed are not needed or are not optimally effective. This significant threat to human health is starting to be addressed technologically through the development and commercialization of novel rapid diagnostics. The approaches include phenotypic and genotypic methodologies that target a variety of direct and indirect biomarkers, including protein, lipid, and cell-based phenotypic assays as well as molecular diagnostic approaches. One of the key areas of innovation is the development and integration of appropriate and easy to use sample preparation that is tailored to the target analyte, the specimen, and the diagnostic modality. A survey of key innovations in the field will be presented.
For more information, please see the event website.